123 related articles for article (PubMed ID: 14983944)
1. Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays.
Proctor KA; Rao LV; Roberts WL
Am J Clin Pathol; 2004 Feb; 121(2):282-92. PubMed ID: 14983944
[TBL] [Abstract][Full Text] [Related]
2. Interference of gadolinium-based contrast agents on colorimetric calcium assays.
Yan R; Tarr H; McNally M; Cartier LJ; Chen Y
Clin Biochem; 2014 May; 47(7-8):648-53. PubMed ID: 24365398
[TBL] [Abstract][Full Text] [Related]
3. Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements.
Zhang HL; Ersoy H; Prince MR
J Magn Reson Imaging; 2006 Mar; 23(3):383-7. PubMed ID: 16463306
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic systemic fibrosis risk: is there a difference between gadolinium-based contrast agents?
Penfield JG; Reilly RF
Semin Dial; 2008; 21(2):129-34. PubMed ID: 18225999
[TBL] [Abstract][Full Text] [Related]
5. Measurement of serum calcium concentration after administration of four gadolinium-based contrast agents to human volunteers.
Brown JJ; Hynes MR; Wible JH
AJR Am J Roentgenol; 2007 Dec; 189(6):1539-44. PubMed ID: 18029898
[TBL] [Abstract][Full Text] [Related]
6. Measurement of serum calcium concentration after administration of gadoversetamide in dogs.
Wible JH; Hynes MR
Radiology; 2004 Oct; 233(1):158-64. PubMed ID: 15454620
[TBL] [Abstract][Full Text] [Related]
7. Interference of gadolinium-containing contrast-enhancing agents with colorimetric calcium laboratory testing.
Löwe A; Balzer T; Hirt U
Invest Radiol; 2005 Aug; 40(8):521-5. PubMed ID: 16024990
[TBL] [Abstract][Full Text] [Related]
8. Influence of magnetic resonance contrast media on the activity of histamine inactivating enzymes.
Kuefner MA; Feurle J; Uder M; Bautz W; Schwelberger HG
Acad Radiol; 2009 Mar; 16(3):358-62. PubMed ID: 19201365
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interference.
Gandhi MJ; Narra VR; Brown JJ; Guo A; Grosu DS; Parvin CA; Scott MG
AJR Am J Roentgenol; 2008 Mar; 190(3):W213-7. PubMed ID: 18287415
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review.
Idée JM; Port M; Raynal I; Schaefer M; Le Greneur S; Corot C
Fundam Clin Pharmacol; 2006 Dec; 20(6):563-76. PubMed ID: 17109649
[TBL] [Abstract][Full Text] [Related]
11. Automated colorimetric gadolinium assay for verification of clearance and estimation of glomerular filtration rate.
Magnotti RA; Connell JL; Marietta PM
Clin Chim Acta; 2009 Jan; 399(1-2):59-63. PubMed ID: 18834869
[TBL] [Abstract][Full Text] [Related]
12. Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media.
Runge VM; Dickey KM; Williams NM; Peng X
Invest Radiol; 2002 Jul; 37(7):393-8. PubMed ID: 12068161
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance contrast agents in neuroimaging. New agents and applications.
Runge VM; Kirsch JE; Wells JW; Dunworth JN; Awh MH; Bittner DF
Neuroimaging Clin N Am; 1994 Feb; 4(1):175-83. PubMed ID: 8130948
[TBL] [Abstract][Full Text] [Related]
14. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of two gadolinium-containing contrast-enhancing agents, gadobutrol and gadoxetate disodium, on colorimetric calcium determinations in serum and plasma.
Löwe A; Breuer J; Palkowitsch P
Invest Radiol; 2011 Jun; 46(6):366-9. PubMed ID: 21285889
[TBL] [Abstract][Full Text] [Related]
16. Analytical interference in serum iron determination reveals iron versus gadolinium transmetallation with linear gadolinium-based contrast agents.
Fretellier N; Poteau N; Factor C; Mayer JF; Medina C; Port M; Idée JM; Corot C
Invest Radiol; 2014 Dec; 49(12):766-72. PubMed ID: 24943092
[TBL] [Abstract][Full Text] [Related]
17. Calcium binding by gadolinium-based MR contrast agents.
Hayakawa K; Nakamura T; Shimizu Y
Radiat Med; 2005 Dec; 23(8):545-9. PubMed ID: 16555562
[TBL] [Abstract][Full Text] [Related]
18. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
Caravan P
Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
[TBL] [Abstract][Full Text] [Related]
19. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
20. Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, Hemospan.
Cameron SJ; Gerhardt G; Engelstad M; Young MA; Norris EJ; Sokoll LJ
Clin Biochem; 2009 Feb; 42(3):221-4. PubMed ID: 19028481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
